Michael Lawrence Schwartz

Michael Schwartz practices at Rockland Thoracic & Vascular Associates in Pomona, New York.

Michael Schwartz's NPI, 1013915784, was assigned on July 7, 2005. Michael Schwartz graduated from University of South Florida Morsani College of Medicine in 1988. Michael Schwartz holds New York license 181505.

Michael Schwartz's primary practice is Rockland Thoracic & Vascular Associates, at 5 Medical Park Dr, Pomona, NY 10970 in Rockland County. The practice phone is (845) 362-0075.

Michael Schwartz's primary practice is Rockland Thoracic & Vascular Associates in Pomona, New York. Michael Schwartz is also affiliated with Garnet Health Medical Center. The medical group on file is Rockland Thoracic & Vascular Associates. Dmand AI also links Michael Schwartz to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Schwartz practices, 9 sites in all. Vendor and product names are available with a free account.

Surgery is Michael Schwartz's primary specialty in the NPI Registry, under taxonomy code 208600000X. Michael Schwartz is licensed in New York.

CMS data shows 3,358 Medicare services from Michael Schwartz across 23 procedure codes in 2024, for 1,264 Medicare patients. Medicare paid $456,176 for them.

CMS counts 1,264 Medicare patients who saw Michael Schwartz in 2024. The largest group is 75 to 84, with 580 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Schwartz's median patient age at 73, with 54% women.

In 2024, Michael Schwartz wrote 210 Medicare Part D claims for 96 patients. 85% of them were for generic drugs. CMS names the drug for 118 of them, across 4 drugs with 11 or more claims each, at $11,521 in total drug cost. In 2023, CMS named 168 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Michael Schwartz for performance year 2024, reported as part of a group. Michael Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Schwartz as offering telehealth. CMS counts 29 procedures of leg revascularization (restoring blood flow) by Michael Schwartz, more than 88% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 294 general payments to Michael Schwartz from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Medtronic Vascular, Inc. paid the most, $19,265.

Michael Schwartz graduated from University of South Florida Morsani College of Medicine in 1988.